NEUSPERA MEDICAL
NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology.
NEUSPERA MEDICAL
Social Links:
Industry:
Biopharma Health Care Medical Device
Founded:
2013-12-03
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.neuspera.com
Total Employee:
11+
Status:
Active
Contact:
1(888)846-8332
Email Addresses:
[email protected]
Total Funding:
111.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Treo Ventures
Treo Ventures investment in Series C - NeuSpera Medical
Vertex Ventures HC
Vertex Ventures HC investment in Series C - NeuSpera Medical
Action Potential Venture Capital
Action Potential Venture Capital investment in Series C - NeuSpera Medical
Windham Venture Partners
Windham Venture Partners investment in Series C - NeuSpera Medical
Windham Venture Partners
Windham Venture Partners investment in Series B - NeuSpera Medical
6 Dimensions Capital
6 Dimensions Capital investment in Series B - NeuSpera Medical
Alumni Ventures
Alumni Ventures investment in Series B - NeuSpera Medical
Delta Capital Management
Delta Capital Management investment in Series B - NeuSpera Medical
Action Potential Venture Capital
Action Potential Venture Capital investment in Series B - NeuSpera Medical
Alumni Ventures
Alumni Ventures investment in Series B - NeuSpera Medical
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-06 | Neuspera Medical® Appoints Steffen Hovard as CEO |
Official Site Inspections
http://www.neuspera.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeuSpera Medical"
Neuspera Medical | Implantable Medical Device Technology | OAB
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness.See details»
Neuspera | Minimally Invasive Implantable Medical …
Neuspera® Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. The company’s proprietary Mid-Field Powering Technology allows devices to be …See details»
NeuSpera Medical - Crunchbase Company Profile
NeuSpera Medical develops implantable medical device technology to treat chronic illnesses through minimally invasive solutions. NeuSpera focuses on bioelectronic medicine and has developed ultra-miniaturized implants using …See details»
Neuspera Medical Inc. - LinkedIn
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness.See details»
Neuspera Company Profile 2024: Valuation, Funding & Investors
Developer of implantable medical devices designed to improve the lives of patients battling chronic illness. The company offers implantable neuromodulation devices that use mid-field …See details»
Neuspera Medical® announces first successful implant …
Oct 13, 2022 · SAN JOSE, Calif., Oct. 10, 2022 /PRNewswire/ — Neuspera® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced the first patient successfully …See details»
Neuspera Medical secures $23m for SNM system
Jul 16, 2024 · Neuspera Medical has closed its Series D funding round, securing $23m to advance its Implantable Sacral Neuromodulation (SNM) System towards US Food and Drug Administration (FDA) premarket approval.See details»
New OAB Treatment on the Horizon: Neuspera System
The Neuspera Implantable Sacral Neuromodulation (SNM) System is the smallest device of its kind. There are several unique features of the Neuspera System, including: 1. Minimally …See details»
Electroceuticals startup NeuSpera raises $8M to back tiny, …
May 12, 2016 · Now, it's raised an $8 million Series A financing after bringing in a high-profile exec to lead its effort. The Santa Clara, CA-based startup is aiming for a futuristic field that …See details»
NEUSPERA MEDICAL® ANNOUNCES FIRST …
SAN JOSE, Calif., Oct. 10, 2022 /PRNewswire/ -- Neuspera® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today announced the first...See details»
Neuspera Medical® Appoints Steffen Hovard as CEO
SAN JOSE, Calif., Sept. 6, 2022 /PRNewswire/ — Neuspera® Medical, a medical device company developing implantable medical device technology for patients with chronic illness, …See details»
Neuspera Medical scores $65M for nerve-stimulating implant to …
Jul 20, 2021 · Neuspera Medical’s miniaturized neuromodulation device may take up mere millimeters of space, but it’s making an outsized impact on the field of medical technology. The …See details»
Neuspera Medical, Inc. Completes Patient Enrollment and Implants …
Dec 8, 2023 · The international study is evaluating the safety and efficacy of the Neuspera System for the treatment of urinary urge incontinence (UUI), a symptom of overactive bladder …See details»
NEUSPERA MEDICAL® ANNOUNCES FDA CLEARANCE OF ITS …
SAN JOSE, Calif., April 18, 2023 /PRNewswire/ -- Neuspera ® Medical, a medical device company developing implantable devices for patients battling chronic illnesses, today …See details»
Neuspera Announces Leadership Expansion with the Addition of …
Aug 4, 2022 · Neuspera® Medical, a medical device company developing implantable medical device technology for patients battling chronic illness, today announced the hiring of Steven …See details»
Neuspera Medical, Inc. Announces Milestone Completion of 100th …
Nov 14, 2023 · Neuspera Medical, Inc. is committed to developing implantable medical devices that will improve the lives of patients battling chronic illnesses. The Neuspera platform is …See details»
FDA Clears Neurostimulation System for Chronic Peripheral Nerve …
Oct 18, 2024 · The FDA has cleared the Neuspera micro-implant neurostimulation system (Neuspera Medical) to treat chronic peripheral nerve pain through a wireless platform, …See details»
Neuspera Medical, Inc. Completes Patient Enrollment and Implants …
Dec 6, 2023 · Neuspera Medical, Inc. is committed to developing implantable medical devices that will improve the lives of patients battling chronic illnesses. The Neuspera platform is designed …See details»
Reflief from Overactive Bladder | Patients - Neuspera
Neuspera’s SNM treatment is designed to provide relief from the limiting effects of UUI with a minimally-invasive procedure and an external wearable that fits into your lifestyle. The …See details»
Neuspera Medical Completes First Implants of its …
Jun 10, 2020 · Neuspera Medical, Inc. is privately held, venture-backed, clinical stage neuromodulation company committed to developing implantable medical device technology …See details»